상처 치료 시장 : 2027년까지의 세계 예측

출판 : MarketsandMarkets(마켓츠앤마켓츠)출판년월 : 2022년06월

상처 치료 시장 : 제품[드레싱(폼, 필름, 하이드로콜로이드, 콜라겐), 디바이스(NPWT, 평가, 창면 절제), 그래프트, 매트릭스, 봉합사, 스테이플러], 상처(DFU, 외상, 수술, 화상), 최종 사용자(병원, 클리닉) & 지역별 – 2027년까지의 세계 예측
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

페이지수 308
도표수 287
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spendings on traumatic wound management.
세계 상처 치료 시장은 예측 기간 동안 5.4%의 CAGR로 2022년 208억 달러에서 2027년 272억 달러에 이를 것으로 예상됩니다. 시장 성장은 외상성 부상 증가, 수술 상처 수 증가, 외상성 상처 관리에 대한 지출 증가와 같은 요인에 의해 주도됩니다.

On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market.
“The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period”
The wound care market is segmented into advanced wound care products, surgical wound care products and traditional wound care products. In 2021, the advanced wound care products segment accounted for the highest growth rate in the wound care market. Increasing incidence of traumatic and surgical wounds are major factor contributing to the growth of this segment.
“The diabetic foot ulcers segment accounted for the highest growth rate in the wound care market, by wound type, during the forecast period”
The wound care market is segmented into surgical & traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers and burns & other wounds based on wound type. In 2021, the diabetic foot ulcers segment accounted for the highest growth rate in the wound care market. Rising technological advancements In the development of cancer biomarkers and increasing incidence of diabetes and other health conditions are major factors contributing to the growth of this segment.
“Hospitals and clinics segment accounted for the highest share”
Based on end users, the wound care market has been segmented into hospitals and clinics, long-term patient care, home care settings and other end users. In 2021, the home care settings segment accounted for the highest CAGR. This can be attributed to the increasing focus on surgical wounds.

“Asia Pacific: The fastest-growing region in wound care market”
The global wound care market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Rising focus on decreasing the surgical wounds and increased focus on traumatic wound management are driving the growth of the wound care market in this region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6% , and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:

• 3M Company (US)
• Smith & Nephew PLC (UK)
• Cardinal Health (US)
• Medtronic PLC (Ireland)
• B. Braun Melsungen AG (Germany)
• Baxter International, Inc. (US)
• Mölnlycke Health Care AB (Sweden)
• Convatec Group (UK)
• Paul Hartmann AG (Germany)
• Coloplast A/S (Denmark)
• Organogenesis Holdings Inc. (US)
• MiMedx Group, Inc. (US)
• Integra Life Sciences Holdings Corporation (US)
• Bioventus (US)
• Zimmer Biomet Holdings, Inc. (US)
• Ethicon, Inc. (US)
• DeRoyal Industries (US)
• Kerecis (Iceland)
• Acell (US)
• Lohmann & Rauscher GmbH & Co. KG (Germany)
• Medela Ag (Switzerland)
• Talley Group (UK)
• Welcare Industries SPA (Italy)
• Wuhan VSD Medical Science & Technology Co. Ltd. (China)
• Pensar Medical (US)
• Haromed BVBA (Belgium)
• DermaRite Industries LLC (US)
• Medline Industries, Inc. (US)
• Advancis Medical LLC (UK)
• Mil Laboratories Pvt. Ltd. (India).


Research Coverage:
This report provides a detailed picture of the global wound care market. It aims at estimating the size and future growth potential of the market across different segments, such as products, wound type , end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall wound care market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 35)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
1.3 MARKETS COVERED
1.3.1 WOUND CARE MARKET
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 40)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 1 WOUND CARE MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key data from primary sources
2.2.2.3 Key industry insights
2.2.2.4 Breakdown of primary interviews
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 Approach 3: Presentations of companies and primary interviews
2.3.1.3 Growth forecast
2.3.1.4 CAGR projections
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH
FIGURE 6 WOUND CARE MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS
2.8 GROWTH RATE ASSUMPTIONS
2.9 RISK ASSESSMENT
2.9.1 RISK ASSESSMENT: WOUND CARE MARKET

3 EXECUTIVE SUMMARY (Page No. – 52)
FIGURE 8 WOUND CARE MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 WOUND CARE MARKET, BY WOUND TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 WOUND CARE MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 11 WOUND CARE MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. – 55)
4.1 WOUND CARE MARKET OVERVIEW
FIGURE 12 GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE THE MARKET GROWTH
4.2 WOUND CARE MARKET SHARE, BY PRODUCT, 2022 VS. 2027
FIGURE 13 THE ADVANCED WOUND CARE PRODUCTS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.3 WOUND CARE MARKET SHARE, BY WOUND TYPE, 2022 VS. 2027
FIGURE 14 SURGICAL & TRAUMATIC SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.4 WOUND CARE MARKET SHARE, BY END USER, 2022 VS. 2027
FIGURE 15 THE HOSPITALS AND CLINICS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.5 WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 THE ASIA PACIFIC REGION IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 58)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diseases & health conditions that affect wound healing capabilities
5.2.1.1.1 Growing geriatric population
5.2.1.1.2 Rising prevalence of diabetes
FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2045 (MILLION CASES)
5.2.1.1.3 Increasing number of surgical procedures worldwide
TABLE 1 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED IN THE US
5.2.2 RISING EXPENDITURE ON CHRONIC WOUNDS
5.2.3 INCREASING INCIDENCE OF BURN INJURIES
5.2.4 RISING CASES OF TRAUMATIC INJURIES
TABLE 2 PREVALENCE OF ROAD ACCIDENTS
5.2.5 TECHNOLOGICAL ADVANCEMENTS IN WOUND CARE PRODUCTS
5.2.6 RISING USE OF REGENERATIVE MEDICINE FOR WOUND MANAGEMENT
5.2.7 RESTRAINTS
5.2.7.1 High costs of advanced wound care products
TABLE 3 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS
5.2.7.2 Risks associated with the use of advanced wound care products
TABLE 4 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
5.2.8 OPPORTUNITIES
5.2.8.1 Growth potential of emerging countries
TABLE 5 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC REGION
5.2.9 TRENDS
5.2.9.1 Acquisitions by leading companies in the market
5.2.9.1.1 Rising focus on expanding current technologies and launching novel products
5.2.9.1.2 Smart wound dressings for minimum invasiveness
5.2.9.1.3 Crab shell bandages
5.2.9.1.4 Color-changing dressings
5.2.9.1.5 Integration of nanotechnology in advanced wound care products
5.2.9.1.6 Novel wound assessment & measurement devices
5.3 IMPACT OF COVID-19 ON THE WOUND CARE MARKET
5.4 PRICING ANALYSIS
TABLE 6 AVERAGE SELLING PRICE OF WOUND CARE PRODUCTS (2022)
5.5 PATENT ANALYSIS
FIGURE 19 PATENT ANALYSIS OF THE WOUND CARE MARKET
5.5.1 LIST OF MAJOR PATENTS
5.6 VALUE CHAIN ANALYSIS
FIGURE 20 VALUE CHAIN ANALYSIS OF THE WOUND CARE MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 21 WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM/MARKET MAP
FIGURE 22 WOUND CARE MARKET: ECOSYSTEM/MARKET MAP
5.8.1 WOUND CARE MARKET: ECOSYSTEM ROLE
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT FROM NEW ENTRANTS
5.9.2 THREAT FROM SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 DEGREE OF COMPETITION
5.10 REGULATORY LANDSCAPE
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 Canada
5.10.2 EUROPE
5.10.3 ASIA PACIFIC
5.10.3.1 China
5.10.3.2 Japan
5.10.3.3 India
5.10.4 LATIN AMERICA
5.10.4.1 Brazil
5.10.4.2 Mexico
5.10.5 MIDDLE EAST
5.10.6 AFRICA
5.11 TRADE ANALYSIS
5.11.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS
5.11.1.1 Import data for adhesive dressings by country, 2017–2021 (USD million)
5.11.1.2 Export data for adhesive dressings by country, 2017–2021 (USD million)
5.12 TECHNOLOGY ANALYSIS
5.13 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 12 WOUND CARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14.1 REVENUE SOURCES ARE SHIFTING TOWARDS TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC
5.14.2 REVENUE SHIFT IN THE WOUND CARE MARKET
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
FIGURE 23 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS
TABLE 13 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS (%)
5.15.2 BUYING CRITERIA
FIGURE 24 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS
TABLE 14 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS
5.16 CASE STUDIES
5.16.1 CASE STUDY: TIELLE ESSENTIAL SILICONE FOAM DRESSINGS USED IN A NON-HEALING DIABETIC FOOT ULCER ON THE RIGHT FOOT

6 WOUND CARE MARKET, BY PRODUCT (Page No. – 88)
6.1 INTRODUCTION
TABLE 15 WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.1.1 PRIMARY NOTES
6.1.1.1 Key industry insights
6.2 ADVANCED WOUND CARE PRODUCTS
TABLE 16 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 17 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1 ADVANCED WOUND CARE DRESSINGS
TABLE 18 ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 19 ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1.1 Foam dressings
TABLE 20 KEY PRODUCTS IN THE FOAM DRESSINGS MARKET
TABLE 21 FOAM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 22 FOAM DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1.1.1 Silicone dressings
6.2.1.1.1.1 Silicone dressings help expedite wound closure and reduce the risk of maceration – a key factor driving the market growth
TABLE 23 SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.1.2 Non-silicone dressings
6.2.1.1.2.1 Non-silicone dressings are effective in scar removal and wound healing
TABLE 24 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2 Hydrocolloid dressings
6.2.1.2.1 Hydrocolloid dressings are cost-effective and promote a moist environment which is required for optimal healing
TABLE 25 KEY PRODUCTS IN THE HYDROCOLLOID DRESSINGS MARKET
TABLE 26 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.3 Film dressings
6.2.1.3.1 The non-absorbable nature of film dressings ensures strong adoption
TABLE 27 FILM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.4 Alginate dressings
6.2.1.4.1 Alginate dressings are well suited for diabetic & foot ulcers
TABLE 28 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.5 Hydrogel dressings
6.2.1.5.1 Hydrogel dressings are available in several forms for effective use
TABLE 29 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.6 Collagen dressings
6.2.1.6.1 A favorable reimbursement scenario for collagen dressings to support the market growth
TABLE 30 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.7 Hydrofiber dressings
6.2.1.7.1 Hydrofiber dressings combine the properties of hydrocolloids and collagen
TABLE 31 HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.8 Wound contact layers
6.2.1.8.1 Wound contact layers protect wound beds from bacterial & fungal growth
TABLE 32 WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.9 Superabsorbent dressings
6.2.1.9.1 Superabsorbent dressings are designed for highly exuding wounds
TABLE 33 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.10 Other advanced wound care dressings
TABLE 34 OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 36 NON-ANTIMICROBIAL DRESSINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 37 ANTIMICROBIAL DRESSINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 WOUND THERAPY DEVICES
TABLE 38 WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 39 WOUND THERAPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.2.1 Portable & conventional negative pressure wound therapy devices (NPWT)
6.2.2.1.1 Growing adoption of single-use NPWT devices in homecare to drive the market growth
TABLE 40 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2 Debridement devices & accessories
6.2.2.2.1 Development of novel technologies to support the growth of this segment
TABLE 41 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.3 Wound assessment & monitoring devices
6.2.2.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost its adoption
TABLE 42 WOUND ASSESSMENT & MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 OTHER DEVICES & ACCESSORIES
TABLE 43 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4 GRAFTS & MATRICES
6.2.4.1 Grafts & matrices promote healing & wound closure
TABLE 44 KEY PRODUCTS IN THE GRAFTS & MATRICES MARKET
TABLE 45 GRAFTS & MATRICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.5 TOPICAL AGENTS
6.2.5.1 Cost-effectiveness & ease-of-use in home care settings to drive the growth of this segment
TABLE 46 TOPICAL AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 SURGICAL WOUND CARE PRODUCTS
TABLE 47 SURGICAL CARE PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 48 SURGICAL CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.3.1 SUTURES
6.3.1.1 Increasing number of surgical procedures and the high tensile strength afforded by sutures drive the market growth
TABLE 49 SUTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 STAPLERS
6.3.2.1 Staplers are considered to be more accurate than suturing and less likely to allow leakage; a key factor driving adoption
TABLE 50 STAPLERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3 TISSUE ADHESIVES, SEALANTS, AND GLUES
TABLE 51 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
TABLE 52 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.3.1 Fibrin-based sealants
6.3.3.1.1 Fibrin-based sealants provide better results than sutures, thus driving the product demand
TABLE 53 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3.2 Collagen-based sealants
6.3.3.2.1 Collagen-based sealants are used in surgical procedures as an adjunctive to hemostatic agents
TABLE 54 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3.3 Synthetic adhesives
6.3.3.3.1 Synthetic adhesives have additional sealing properties than traditional staples; a key factor driving the segment growth
TABLE 55 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 TRADITIONAL WOUND CARE PRODUCTS
TABLE 56 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 57 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.4.1 MEDICAL TAPES
6.4.1.1 Latex-free tapes are gentle to the skin and hypoallergenic for sensitive patients
TABLE 58 MEDICAL TAPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.2 DRESSINGS
6.4.2.1 Presence of a large patient population for pressure ulcers has ensured a sustained demand for these products
TABLE 59 DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.3 CLEANSING AGENTS
6.4.3.1 High risk of HAIs from open wounds to drive the market growth
TABLE 60 TYPES OF CLEANSING AGENTS
TABLE 61 CLEANSING AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 WOUND CARE MARKET, BY WOUND TYPE (Page No. – 136)
7.1 INTRODUCTION
TABLE 62 WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
7.2 SURGICAL & TRAUMATIC WOUNDS
7.2.1 THE RISING VOLUME OF SURGICAL PROCEDURES DRIVES THE GROWTH OF THIS SEGMENT
TABLE 63 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 DIABETIC FOOT ULCERS
7.3.1 INCREASING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 64 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2021 (20-79 AGE GROUP)
TABLE 65 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 PRESSURE ULCERS
7.4.1 GROWING GERIATRIC POPULATION TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 66 WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 VENOUS LEG ULCERS
7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 67 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 BURNS AND OTHER WOUNDS
7.6.1 HIGH INCIDENCE OF BURN INJURIES TO DRIVE THE MARKET GROWTH
TABLE 68 WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2020–2027 (USD MILLION)

8 WOUND CARE MARKET, BY END USER (Page No. – 146)
8.1 INTRODUCTION
TABLE 69 WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS AND CLINICS
TABLE 70 TOTAL NUMBER OF HOSPITALS, BY COUNTRY (IN 2019)
TABLE 71 WOUND CARE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 72 WOUND CARE MARKET FOR HOSPITALS AND CLINICS, BY TYPE, 2020–2027 (USD MILLION)
8.2.1 INPATIENT SETTINGS
8.2.1.1 Increasing hospital admissions due to HAIs to drive the growth of this segment
TABLE 73 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 OUTPATIENT SETTINGS
8.2.2.1 Rising costs of inpatient facilities drive the demand for outpatient care settings
TABLE 74 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 LOW COSTS AND CONVENIENCE TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
TABLE 75 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 LONG-TERM CARE FACILITIES
8.4.1 GROWTH IN THE GERIATRIC & VULNERABLE POPULATIONS DRIVES THE DEMAND FOR BETTER LONG-TERM CARE
TABLE 76 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 77 WOUND CARE MARKET FOR OTHER END-USERS, BY COUNTRY, 2020–2027 (USD MILLION)

9 WOUND CARE MARKET, BY REGION (Page No. – 156)
9.1 INTRODUCTIONS
TABLE 78 WOUND CARE MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT
TABLE 79 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 81 NORTH AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 82 NORTH AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 83 NORTH AMERICA: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 84 NORTH AMERICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 85 NORTH AMERICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 86 NORTH AMERICA: WOUND CARE MARKET; BY TISSUES ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 87 NORTH AMERICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 88 NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 89 NORTH AMERICA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Rising incidence of chronic diseases and diabetes to drive the market growth
TABLE 90 US: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 91 US: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 High prevalence of HAIs drives the market growth for wound care management in Canada
TABLE 92 INCIDENCE OF DIABETES IN CANADA, 2019 VS. 2029
TABLE 93 CANADA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 94 CANADA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 95 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)
TABLE 96 PREVALENCE OF DIABETES IN EUROPE, 2019 VS. 2045
TABLE 97 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 98 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 EUROPE: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 100 EUROPE: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 101 EUROPE: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 102 EUROPE: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 103 EUROPE: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 104 EUROPE: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 105 EUROPE: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 106 EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 107 EUROPE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 The large diabetic population in Germany has supported product development & commercialization for the wound care market
TABLE 108 GERMANY: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 109 GERMANY: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 The rising senior population drives the market growth in France
TABLE 110 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 111 FRANCE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 UK
9.3.3.1 Rising incidence of chronic wounds to propel market growth in the UK
TABLE 112 UK: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 113 UK: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growth in this market is driven by improving quality & accessibility to medical care and products
TABLE 114 ITALY: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 115 ITALY: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing life expectancies and the growing geriatric population to ensure the market growth in Spain
TABLE 116 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 SPAIN: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 RUSSIA
9.3.6.1 Government focus on increasing diabetes awareness to favor the market growth
TABLE 118 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 119 RUSSIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 120 ROE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 ROE: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 122 ROE: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 123 ROE: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 124 ROE: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 125 ROE: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 126 ROE: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 127 ROE: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 128 ROE: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 129 ROE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 26 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT
TABLE 130 ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 131 ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 132 ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 133 ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 134 ASIA PACIFIC: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 135 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 136 ASIA PACIFIC: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 137 ASIA PACIFIC: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 138 ASIA PACIFIC: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 139 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 140 ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Increasing incidence of DFUs to support the market growth in China
TABLE 141 CHINA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 142 CHINA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Implementations of regulations in Japan have resulted in a favorable environment for wound care devices
TABLE 143 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 144 JAPAN: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing medical tourism in India to support the market growth for wound care management
TABLE 145 INDIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 146 INDIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Increasing initiatives to spread awareness on effective wound care to support the market growth
TABLE 147 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 148 AUSTRALIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Local manufacturers in South Korea are partnering with research organizations for advanced wound care products; a key growth driver
TABLE 149 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 150 SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.6 SINGAPORE
9.4.6.1 The growing prevalence of diabetes drives the market growth in Singapore
TABLE 151 SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 152 SINGAPORE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.7 REST OF ASIA PACIFIC
TABLE 153 ROAPAC: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 154 ROAPAC: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 155 ROAPAC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 156 ROAPAC: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 157 ROAPAC: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 158 ROAPAC: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 159 ROAPAC: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 160 ROAPAC: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 161 ROAPAC: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 162 ROAPAC: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 163 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 164 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 165 LATIN AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 166 LATIN AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 167 LATIN AMERICA: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 168 LATIN AMERICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 169 LATIN AMERICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 170 LATIN AMERICA: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil is the largest healthcare market in Latin America
TABLE 174 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 175 BRAZIL: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico
TABLE 176 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 177 MEXICO: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 178 ROLATAM: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 179 ROLATAM: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 180 ROLATAM: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 181 ROLATAM: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 182 ROLATAM: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 183 ROLATAM: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 184 ROLATAM: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 185 ROLATAM: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 186 ROLATAM: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 187 ROLATAM: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 RISING PREVALENCE OF DIABETES IN THE REGION TO SUPPORT THE MARKET GROWTH
TABLE 188 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 190 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION)
TABLE 193 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 194 MIDDLE EAST & AFRICA: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. – 219)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE WOUND CARE MARKET
TABLE 198 OVERVIEW OF STRATEGIES DEPLOYED BY KEY WOUND CARE MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 27 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET
10.4 MARKET SHARE ANALYSIS
10.4.1 WOUND CARE MARKET
FIGURE 28 WOUND CARE MARKET SHARE BY KEY PLAYER (2021)
TABLE 199 WOUND CARE MARKET: DEGREE OF COMPETITION
10.4.1.1 Advanced wound care
FIGURE 29 GLOBAL WOUND CARE MARKET SHARE FOR ADVANCED WOUND CARE BY KEY PLAYERS (2021)
10.4.1.2 Negative pressure wound therapy (NPWT)
FIGURE 30 GLOBAL WOUND CARE MARKET SHARE FOR NPWT BY KEY PLAYER (2021)
10.4.1.3 Advanced wound dressings
FIGURE 31 GLOBAL WOUND CARE MARKET RANKING FOR ADVANCED WOUND DRESSINGS, BY KEY PLAYER, 2021
10.4.1.4 Surgical sutures
FIGURE 32 GLOBAL WOUND CARE MARKET RANKING FOR SURGICAL SUTURES, BY KEY PLAYER, 2021
10.4.1.5 Debridement devices
FIGURE 33 GLOBAL WOUND CARE MARKET RANKING FOR DEBRIDEMENT DEVICES, BY KEY PLAYER, 2021
10.4.1.6 Traditional and surgical wound care product markets
TABLE 200 GLOBAL WOUND CARE MARKET RANKING FOR TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS, BY KEY PLAYER, 2021
10.5 COMPANY EVALUATION QUADRANT
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 34 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 35 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
FIGURE 36 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET
TABLE 201 WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 202 COMPANY PRODUCT & SERVICE FOOTPRINT
TABLE 203 COMPANY REGIONAL FOOTPRINT
TABLE 204 WOUND CARE MARKET: DETAILED LIST OF KEY START-UPS/SMES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 205 KEY PRODUCT LAUNCHES &
10.8.2 DEALS
TABLE 206 KEY DEALS

11 COMPANY PROFILES (Page No. – 234)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 3M COMPANY
TABLE 207 3M COMPANY: BUSINESS OVERVIEW
FIGURE 37 3M COMPANY: BUSSINESS OVERVIEW (2021)
11.1.2 CARDINAL HEALTH
TABLE 208 CARDINAL HEALTH.: BUSINESS OVERVIEW
FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2021)
11.1.3 MEDTRONIC PLC
TABLE 209 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 39 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.4 B. BRAUN MELSUNGEN AG
TABLE 210 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 40 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2021)
11.1.5 SMITH & NEPHEW PLC
TABLE 211 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 41 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
11.1.6 MÖLNLYCKE HEALTH CARE AB
TABLE 212 MÖLNLYCKE HEALTH CARE AB: BUSINESS OVERVIEW
FIGURE 42 MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2021)
11.1.7 PAUL HARTMANN AG
TABLE 213 PAUL HARTMANN AG: BUSINESS OVERVIEW
FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2021)
11.1.8 CONVATEC GROUP
TABLE 214 CONVATEC GROUP: BUSINESS OVERVIEW
FIGURE 44 CONVATEC GROUP: COMPANY SNAPSHOT (2021)
11.1.9 ZIMMER BIOMET HOLDINGS INC.
TABLE 215 ZIMMER BIOMET HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 45 ZIMMER BIOMET HOLDINGS INC.: COMPANY SNAPSHOT (2021)
11.1.10 BAXTER INTERNATIONAL, INC.
TABLE 216 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 46 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021)
11.1.11 ORGANOGENESIS HOLDINGS INC.
TABLE 217 ORGANOGENESIS HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 47 ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT (2021)
11.1.12 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 218 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 48 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
11.1.13 COLOPLAST A/S
TABLE 219 COLOPLAST A/S: BUSINESS OVERVIEW
FIGURE 49 COLOPLAST A/S: COMPANY SNAPSHOT (2021)
11.1.14 MIMEDX GROUP, INC.
TABLE 220 MIMEDX GROUP, INC.: BUSINESS OVERVIEW
FIGURE 50 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2021)
11.1.15 BIOVENTUS
TABLE 221 BIOVENTUS: BUSINESS OVERVIEW
FIGURE 51 BIOVENTUS: COMPANY SNAPSHOT (2021)
11.2 OTHER PLAYERS
11.2.1 ETHICON, INC.
TABLE 222 ETHICON, INC.: COMPANY OVERVIEW
11.2.2 DEROYAL INDUSTRIES
TABLE 223 DEROYAL INDUSTRIES: COMPANY OVERVIEW
11.2.3 KERECIS
TABLE 224 KERECIS: COMPANY OVERVIEW
11.2.4 ACELL
TABLE 225 ACELL: COMPANY OVERVIEW
11.2.5 LOHMANN & RAUSCHER GMBH & CO KG.
TABLE 226 LOHMANN & RAUSCHER GMBH & CO KG.: COMPANY OVERVIEW
11.2.6 MEDELA AG
TABLE 227 MEDELA AG: COMPANY OVERVIEW
11.2.7 TALLEY GROUP
TABLE 228 TALLEY GROUP: COMPANY OVERVIEW
11.2.8 WELCARE INDUSTRIES SPA
TABLE 229 ELCARE INDUSTRIES SPA: COMPANY OVERVIEW
11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.
TABLE 230 WUHAN VSD SCIENCE & TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
11.2.10 PENSAR MEDICAL
TABLE 231 PENSAR MEDICAL: COMPANY OVERVIEW
11.2.11 HAROMED BV
TABLE 232 HAROMED BV: COMPANY OVERVIEW
11.2.12 DERMARITE INDUSTRIES LLC
TABLE 233 DERMARITE INDUSTRIES LLC: COMPANY OVERVIEW
11.2.13 MEDLINE INDUSTRIS, INC.
TABLE 234 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW
11.2.14 ADVANCIS MEDICAL LLC
TABLE 235 ADVANCIS MEDICAL LLC: COMPANY OVERVIEW
11.2.15 MIL LABORATORIES PVT. LTD.
TABLE 236 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. – 309)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com